RNF2 ablation reprograms the tumor-immune microenvironment and stimulates durable NK and CD4+ T-cell-dependent antitumor immunity

Document Details

Document Type
Pub Defense Publication
Publication Date
Oct 22, 2021
Source ID
10.1038/s43018-021-00263-z

Entities

People

  • Barry P Sleckman
  • Chao Li
  • Chuan Xing
  • Deborah Della Manna
  • Eddy S Yang
  • Jianmei W Leavenworth
  • Lin Luo
  • Ling Zeng
  • Mao Li
  • Narendra Wajapeyee
  • Peng Xu
  • Sadashib Ghosh
  • Tim Townes
  • William J. Britt
  • Yu Chen
  • Zechen Chong
  • Zhuo Zhang

Organizations

  • American Association for Cancer Research
  • National Institutes of Health
  • United States Department of Defense